MADRID, June 19 (Reuters) - Spanish biotechnology firm Zeltia said on Friday its Genomica unit was developing a test kit for rapid diagnosis of the H1N1 flu virus.
Genomica is working with hospitals in Spain and abroad to make the kit available for the 2009-2010 flu season in the autumn, Zeltia said in a statement.
(Reporting by Tracy Rucinski; editing by Simon Jessop)
COPENHAGEN (Reuters) - Two years of U.N. climate talks reached their climax in Copenhagen on Friday without a deal on carbon emissions cuts, as world leaders tried a last push to agree a new global climate pact. | Video
Citigroup's plan to extract itself from the government's clutches didn't go as planned. For the bank to succeed, one of two things need to happen. Full Article
If the U.S. is serious about creating jobs it should invest in aviation programs, says the chief of the Aerospace Industries Association. Just don't call it a bailout. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
